BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4949163)

  • 1. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 2. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 3. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 5. L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma.
    Schuler D; Koós R; Révész T; Virág I; Gálfi I
    Haematologia (Budap); 1976; 10(2):205-11. PubMed ID: 1071740
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with L-asparaginase.
    Oettgen HF; Tallal L; Tan CC; Murphy ML; Clarkson BD; Golbey RD; Krakoff IH; Karnofsky DA; Burchenal HJ
    Recent Results Cancer Res; 1970; 33():219-35. PubMed ID: 5292718
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Asparaginase, leukemia and cancer].
    Levy D; Boiron M
    Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A summary of the clinical status of asparaginase.
    Burchenal JH
    Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
    [No Abstract]   [Full Text] [Related]  

  • 12. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 15. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T; Holland JF; Meyer P
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract]   [Full Text] [Related]  

  • 16. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.
    Tallal L; Tan C; Oettgen H; Wollner N; McCarthy M; Helson L; Burchenal J; Karnofsky D; Murphy ML
    Cancer; 1970 Feb; 25(2):306-20. PubMed ID: 4905155
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA; Wada JK; Patch MJ; McGehee W
    Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of L-asparginase in children with advanced leukemia.
    Land VJ; Sutow WW; Fernbach DJ; Lane DM; Williams TE
    Cancer; 1972 Aug; 30(2):339-47. PubMed ID: 4626307
    [No Abstract]   [Full Text] [Related]  

  • 20. L-asparaginase and human malignant disease.
    Crowther D
    Nature; 1971 Jan; 229(5281):168-71. PubMed ID: 4923259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.